CIRM (California Institute for Regenerative Medicine) has featured Elixirgen Scientific on their blog. Visit CIRM’s “the Stem Cellar” article to see the content.
Elixirgen Scientific has begun selling a variety of cell-based human disease models after signing a new agreement, which allows the company to produce and distribute cells differentiated from the California Institute for Regenerative Medicine (CIRM)’s human pluripotent stem cell (hPSC) repository
Elixirgen Scientific’s new kit option for Quick-Neuron™ Cholinergic enables high throughput screening for drug discovery and toxicity screening.
Elixirgen Scientific released Quick-Tissue™ Mesoderm Booster and Quick-Tissue™ Endoderm Booster. These new products accelerates human pluripotent stem cell (hPSC) differentiation into tissues from the mesoderm and endoderm layers.
Stop waiting months for tissues! Elixirgen Scientific provides pluripotent stem cell differentiation services with the world’s fastest turnaround time.
Elixirgen Scientific can make global Alzheimer’s disease, Parkinson’s disease, and Muscular Dystrophy research faster and better.
Elixirgen Scientific announced its launch of Nippi’s iMatrix-511 Silk. The product has the same functions and performance as those of iMatrix-511.
Quick-Neuron™ Cholinergic is based on technology licensed from Keio University. The original paper has just been published in Scientific Reports.
Elixirgen Scientific launched Quick-Muscle™ Skeletal, which differentiates stem cells and induced pluripotent stem cells (iPSCs) into skeletal muscle cells in less than one week.